Detalles de la búsqueda
1.
Efficacy and Safety of Non-Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial Fibrillation.
Circulation
; 149(12): 932-943, 2024 03 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38264923
2.
Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants.
Circulation
; 148(12): 936-946, 2023 09 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37621213
3.
A polygenic risk score predicts atrial fibrillation in cardiovascular disease.
Eur Heart J
; 44(3): 221-231, 2023 01 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35980763
4.
Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients With COVID-19: COVID-PACT.
Circulation
; 146(18): 1344-1356, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36036760
5.
Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex.
Circulation
; 145(4): 242-255, 2022 01 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-34985309
6.
Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial.
Circulation
; 143(7): 673-684, 2021 02 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33587659
7.
Clinical Application of a Novel Genetic Risk Score for Ischemic Stroke in Patients With Cardiometabolic Disease.
Circulation
; 143(5): 470-478, 2021 02 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33185476
8.
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
N Engl J Med
; 380(4): 347-357, 2019 01 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-30415602
9.
Edoxaban versus Warfarin in high-risk patients with atrial fibrillation: A comprehensive analysis of high-risk subgroups.
Am Heart J
; 247: 24-32, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34990581
10.
LEGACY: Phase 2a Trial to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of the Anti-EL (Endothelial Lipase) Antibody MEDI5884 in Patients With Stable Coronary Artery Disease.
Arterioscler Thromb Vasc Biol
; 41(12): 3005-3014, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34706556
11.
Evaluation of the atrial fibrillation better care pathway in the ENGAGE AF-TIMI 48 trial.
Europace
; 24(11): 1730-1738, 2022 11 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36017608
12.
Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial.
Eur Heart J
; 42(17): 1698-1706, 2021 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33760027
13.
Predicting Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease Using a Genetic Risk Score: Results From the FOURIER Trial.
Circulation
; 141(8): 616-623, 2020 02 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-31707849
14.
The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism.
Circulation
; 141(20): 1600-1607, 2020 05 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-32223429
15.
Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients.
N Engl J Med
; 379(12): 1107-1117, 2018 09 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-30145941
16.
Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF): Design and Rationale: From the COMBINE AF (A Collaboration between Multiple institutions to Better Investigate Non-vitamin K antagonist oral anticoagulant use in Atrial Fibrillation) Investigators.
Am Heart J
; 233: 48-58, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33296688
17.
Edoxaban versus warfarin in patients with atrial fibrillation in relation to the risk of stroke: A secondary analysis of the ENGAGE AF-TIMI 48 study.
Am Heart J
; 235: 132-139, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33493453
18.
Biomarkers for Risk Assessment in Atrial Fibrillation.
Clin Chem
; 67(1): 87-95, 2021 01 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33313695
19.
Subclinical Atrial Fibrillation and Anticoagulation: Weighing the Absolute Risks and Benefits.
Circulation
; 149(13): 989-992, 2024 03 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38527139
20.
Response by Aggarwal et al to Letter Regarding Article, "Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants".
Circulation
; 149(16): e1111-e1112, 2024 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38620083